News from all angles
(MedPage Today) -- Early treatment with dupilumab (Dupixent) for eosinophilic esophagitis in young children was associated with reduced risk of developing asthma, an observational study showed. Among…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network